These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15345806)

  • 1. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models.
    Baum L; Ng A
    J Alzheimers Dis; 2004 Aug; 6(4):367-77; discussion 443-9. PubMed ID: 15345806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of metals as therapeutic targets in Alzheimer's disease.
    Finefrock AE; Bush AI; Doraiswamy PM
    J Am Geriatr Soc; 2003 Aug; 51(8):1143-8. PubMed ID: 12890080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
    Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
    J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
    Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
    Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
    Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
    Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
    Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
    J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta metal interaction and metal chelation.
    Cuajungco MP; Frederickson CJ; Bush AI
    Subcell Biochem; 2005; 38():235-54. PubMed ID: 15709482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
    Cuajungco MP; Fagét KY
    Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses And Evaluation Of Asymmetric Curcumin Analogues As Potential Multifunctional Agents For The Treatment Of Alzheimer's Disease.
    Zhai P; Xia CL; Tan JH; Li D; Ou TM; Huang SL; Gu LQ; Huang ZS
    Curr Alzheimer Res; 2015; 12(5):403-14. PubMed ID: 25938868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
    Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
    Tahmasebinia F; Emadi S
    Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal chelation, radical scavenging and inhibition of Aβ₄₂ fibrillation by food constituents in relation to Alzheimer's disease.
    Chan S; Kantham S; Rao VM; Palanivelu MK; Pham HL; Shaw PN; McGeary RP; Ross BP
    Food Chem; 2016 May; 199():185-94. PubMed ID: 26775960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
    Domingo JL
    J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metal chelation as a potential therapy for Alzheimer's disease.
    Cuajungco MP; Fagét KY; Huang X; Tanzi RE; Bush AI
    Ann N Y Acad Sci; 2000; 920():292-304. PubMed ID: 11193167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
    Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.